Search - tctmd.com

Displaying 201 - 220 of 313

Sort: Relevancy | Date

News Daily News

Super-Responders in COAPT: Improving MR and QoL Is Key

Shelley Wood

August 24, 2020

News Daily News

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Michael O'Riordan

August 13, 2020

News Daily News

Too Many HF Trial Results Underreported or Never Published

L.A. McKeown

June 23, 2020

News Conference News HRS 2020

Subcutaneous ICD Holds Up Well Against Transvenous Devices

Todd Neale

May 13, 2020

News Daily News

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

Michael O'Riordan

April 15, 2020

News Features

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Michael O'Riordan

April 07, 2020

News Opinion Editor's Corner

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

Shelley Wood

March 16, 2020

News Daily News

LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure

Shelley Wood

March 10, 2020

News Industry News

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

February 25, 2020

News Daily News

MitraClip in the US: As Coverage Update Looms, Some Questions for REPAIR MR

Shelley Wood

January 24, 2020

News Daily News

Transcatheter Tricuspid, Mitral Repair Appear Safe to Combine: Registry Data

Caitlin E. Cox

January 20, 2020

News Daily News

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Michael O'Riordan

January 03, 2020

News Daily News

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

L.A. McKeown

December 06, 2019

News Conference News AHA 2019

Dapagliflozin Has Benefits Across Heart Failure Subgroups

Todd Neale

November 17, 2019

News Daily News

Deaths After Ablation of Atrial Fibrillation ‘Concerning’ in Real-World Analysis

Michael O'Riordan

October 29, 2019

News Conference News TCT 2019

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

Shelley Wood

September 28, 2019

News Opinion Editor's Corner TCT 2019

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

Shelley Wood

September 28, 2019

News Conference News TCT 2019

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

Shelley Wood

September 19, 2019

News Conference News HFSA 2019

New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF

L.A. McKeown

September 18, 2019

News Conference News HFSA 2019

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

L.A. McKeown

September 16, 2019

Advertisement

Super-Responders in COAPT: Improving MR and QoL Is Key

HF Care Gaps May Stem From Patient-Specific Factors, Canadian Study Finds

Too Many HF Trial Results Underreported or Never Published

Subcutaneous ICD Holds Up Well Against Transvenous Devices

Smoker’s Paradox Debunked: Post-STEMI Outcomes Worse in Cigarette Smokers

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

MitraClip in the US: As Coverage Update Looms, Some Questions for REPAIR MR

Transcatheter Tricuspid, Mitral Repair Appear Safe to Combine: Registry Data

Most Secondary Prevention Patients Are Eligible for Multiple Drugs

Hybrid Approach to Reshaping Left Ventricle Offers Hope for HF Patients

Dapagliflozin Has Benefits Across Heart Failure Subgroups

Deaths After Ablation of Atrial Fibrillation ‘Concerning’ in Real-World Analysis

COAPT at 3 Years: Crossover Patients See Benefits From MitraClip

TCT 2019 Day Three: Thowback Saturday Revisits COAPT, PARTNER 2A, and EXCEL

TCT 2019: Pharmacotherapy in PCI, Head-to-Head Valves, YouTube Rappers, and More

New PROVE-HF Data May Reassure Clinicians of Sacubitril/Valsartan Benefit in HFrEF

DEFINE-HF: Dapagliflozin Improves Function and QoL, but Not Biomarkers, in HFrEF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content